BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11861401)

  • 1. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells.
    Shureiqi I; Jiang W; Fischer SM; Xu X; Chen D; Lee JJ; Lotan R; Lippman SM
    Cancer Res; 2002 Feb; 62(4):1178-83. PubMed ID: 11861401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.
    Shureiqi I; Xu X; Chen D; Lotan R; Morris JS; Fischer SM; Lippman SM
    Cancer Res; 2001 Jun; 61(12):4879-84. PubMed ID: 11406566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
    Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 15-lipoxygenase-1 expression may enhance the sensitivity to non-steroidal anti-inflammatory drug-induced apoptosis in colorectal cancers from patients who are treated with the compounds.
    Yoshinaga M; Murao H; Kitamura Y; Koga K; Tsuruta S; Igarashi H; Nakamura K; Takayanagi R
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2324-9. PubMed ID: 17559385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
    Shureiqi I; Chen D; Lee JJ; Yang P; Newman RA; Brenner DE; Lotan R; Fischer SM; Lippman SM
    J Natl Cancer Inst; 2000 Jul; 92(14):1136-42. PubMed ID: 10904086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells.
    Shureiqi I; Jiang W; Zuo X; Wu Y; Stimmel JB; Leesnitzer LM; Morris JS; Fan HZ; Fischer SM; Lippman SM
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9968-73. PubMed ID: 12909723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
    Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
    Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
    Deguchi A; Xing SW; Shureiqi I; Yang P; Newman RA; Lippman SM; Feinmark SJ; Oehlen B; Weinstein IB
    Cancer Res; 2005 Sep; 65(18):8442-7. PubMed ID: 16166323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
    Lovat PE; Oliverio S; Ranalli M; Corazzari M; Rodolfo C; Bernassola F; Aughton K; Maccarrone M; Hewson QD; Pearson AD; Melino G; Piacentini M; Redfern CP
    Cancer Res; 2002 Sep; 62(18):5158-67. PubMed ID: 12234979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.
    Baek SJ; Kim KS; Nixon JB; Wilson LC; Eling TE
    Mol Pharmacol; 2001 Apr; 59(4):901-8. PubMed ID: 11259636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
    Ding XZ; Kuszynski CA; El-Metwally TH; Adrian TE
    Biochem Biophys Res Commun; 1999 Dec; 266(2):392-9. PubMed ID: 10600514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
    Hsi LC; Xi X; Lotan R; Shureiqi I; Lippman SM
    Cancer Res; 2004 Dec; 64(23):8778-81. PubMed ID: 15574791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Hase T; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Int J Oncol; 2004 Apr; 24(4):821-7. PubMed ID: 15010818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Sulindac and Celecoxib in chemoprevention of colorectal cancer via intrinsic pathway of apoptosis: exploring NHE-1, intracellular calcium homeostasis and Calpain 9.
    Vaish V; Sanyal SN
    Biomed Pharmacother; 2012 Mar; 66(2):116-30. PubMed ID: 22390894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer.
    Shureiqi I; Zuo X; Broaddus R; Wu Y; Guan B; Morris JS; Lippman SM
    FASEB J; 2007 Mar; 21(3):743-53. PubMed ID: 17167069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
    Bottone FG; Martinez JM; Alston-Mills B; Eling TE
    Carcinogenesis; 2004 Mar; 25(3):349-57. PubMed ID: 14633654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
    Andrews P; Zhao X; Allen J; Li F; Chang M
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.
    Capo-chichi CD; Roland IH; Vanderveer L; Bao R; Yamagata T; Hirai H; Cohen C; Hamilton TC; Godwin AK; Xu XX
    Cancer Res; 2003 Aug; 63(16):4967-77. PubMed ID: 12941822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Oncogene; 2002 Nov; 21(54):8347-50. PubMed ID: 12447698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.